^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
SYH2043
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
CSPC Pharma
Drug class:
CDK4 inhibitor, CDK6 inhibitor, CDK2 inhibitor
Related drugs:
Phase 1
CSPC Ouyi Pharmaceutical Co., Ltd.
Not yet recruiting
Last update posted :
02/17/2023
Initiation :
03/01/2023
Primary completion :
02/01/2026
Completion :
03/01/2026
HER-2 • ER
|
SYH2043
Share
